# Stem Cell Educator Therapy in Diabetes

> **NCT03390231** · PHASE2 · UNKNOWN · sponsor: **Throne Biotechnologies Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **COMBINATION_PRODUCT:** Stem Cell Educator therapy

## Key facts

- **NCT ID:** NCT03390231
- **Lead sponsor:** Throne Biotechnologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-27
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03390231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03390231, "Stem Cell Educator Therapy in Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03390231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*